Showing results (391-400 of 532) with videos related to
Sort By:
Pageof 54
Zeitschrift Fur Ernahrungswissenschaft|April 29, 1998
Parenteral selenium supplementation in critically ill patients--effects on antioxidant metabolismC Lehmann, M Weber, D Krausch, et al.The Journal of General Virology|June 5, 2015
Arterivirus nsp12 versus the coronavirus nsp16 2'-O-methyltransferase: comparison of the C-terminal cleavage products of two nidovirus pp1ab polyproteinsKathleen C Lehmann, Lisa Hooghiemstra, Anastasia Gulyaeva, et al.Actas Urologicas Espanolas|May 1, 1994
[Torsion and seminoma in a cryptorchid testis]P L Torrús Tendero, F J Merenciano Cortina, M Sánchez Marcos, et al.The Journal of Infection|April 2, 2013
Pegylated interferon plus ribavirin is suboptimal in IL28B CC carriers without rapid responseKarin Neukam, Pablo Barreiro, Antonio Rivero-Juárez, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 26, 2013
A 24-week treatment strategy with pegylated interferon/ribavirin in HIV/hepatitis C virus genotype 3-coinfected patients who achieved a rapid virologic response results in a high sustained virologic response rateAntonio Rivero-Juarez, Luis F López-Cortés, Angela Camacho, et al.Journal of Gastroenterology|May 10, 2014
Microbial mucosal colonic shifts associated with the development of colorectal cancer reveal the presence of different bacterial and archaeal biomarkersL Mira-Pascual, R Cabrera-Rubio, S Ocon, et al.Transplant Infectious Disease : an Official Journal of the Transplantation Society|March 19, 2016
Early non-invasive selection of patients at high risk of severe hepatitis C recurrence after liver transplantationG Crespo, M Gambato, O Millán, et al.European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 4, 2002
Mortality due to liver failure and impact on survival of hepatitis virus infections in HIV-infected patients receiving potent antiretroviral therapyJ Macías, I Melguizo, F J Fernández-Rivera, et al.Journal of Clinical Microbiology|March 7, 2002
Incidence of and risk factors for symptomatic visceral leishmaniasis among human immunodeficiency virus type 1-infected patients from Spain in the era of highly active antiretroviral therapyRafael de La Rosa, Juan A Pineda, Juan Delgado, et al.Journal of Medical Virology|July 18, 2013
Hepatitis C virus genotype 4 in Southern and Central Spain does not originate from recent foreign migration wavesFederico A Di Lello, Karin Neukam, Manuel Parra-Sanchez, et al.Pageof 54